View abstract

This abstract is assigned to sessions

Presentation preference	Oral presentation
Title	Efficacy and Safety of Adalimumab for Chronic/Relapsing Ocular Inflammation in Patients with Vogt-Koyanagi-Harada Disease

Purpose	To investigate efficacy and safety of adalimumab (ADA) treatment for chronic and/or relapsing Vogt-Koyanagi-Harada disease (VKH)
Methods	For 64 VKH patients who received ADA treatment, the medical records were retrospectively investigated.
Results	There was no significant difference in BCVA in LogMAR or LFP between the initiation of ADA and 6 months later. However, the SFCT, ICG score, and PSL amounts were significantly decreased to at 6 months later.
Conclusion	It was suggested that ADA is effective for exacerbation and recurrence of VKH refractory to conventional treatments, and is generally well tolerated with no serious adverse events.
Conflict of interest	No

Authors 1

Last name	TAKEUCHI
Initials of first name(s)	M
Department	Department of Ophthalmology, National Defense Medical College
City	Tokorozawa
Country	Japan

Authors 2

Last name	Herbort
Initials of first name(s)	C
Department	Retinal and Inflammatory Eye Diseases, Centre for Ophthalmic Specialised Care
City	Lausanne
Country	Switzerland

Authors 3

Last name	Suzuki
Initials of first name(s)	K
Department	Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido Universit
City	Sapporo
Country	Japan

Authors 4

Last name	Namba
Initials of first name(s)	K
Department	Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido Universit
City	Sapporo
Country	Japan

Authors 5

Last name	Usui
Initials of first name(s)	Y
Department	Department of Ophthalmology, Tokyo Medical University
City	Tokyo
Country	Japan

Authors 6

Last name	Harada
Initials of first name(s)	Y
Department	Department of Ophthalmology and Visual Science, Graduate School of Biomedical Sciences, Hiroshima Un
City	Hiroshima
Country	Japan

Authors 7

Last name	Kusuhara
Initials of first name(s)	S
Department	Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine
City	Kobe
Country	Japan

Authors 8

Last name	Kaburaki
Initials of first name(s)	T
Department	Department of Ophthalmology, Saitama Medical Centre, Jichi Medical University
City	Saitama
Country	Japan

Authors 9

Last name	Nakai
Initials of first name(s)	K
Department	Department of Ophthalmology, Yodogawa Christian Hospital
City	Osaka
Country	Japan

Authors 10

Last name	Mizuki
Initials of first name(s)	N
Department	Department of Ophthalmology and Visual Science, Graduate School of Medicine, Yokohama City Universit
City	Yokohama
Country	Japan